Similarly, in younger women (< 50 years old), high sclerostin levels correlated with obesity, but in contrast to older postmenopausal women, sclerostin correlated negatively with spine and femoral neck BMD and the trabecular bone score [17, 18, 21]. Here, SOST is linked to obesity disorder.